The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Association of vitamin D intake with decreased risk of immune checkpoint inhibitor-induced colitis.
 
Kevin Tyan
Employment - Kinnos
Leadership - Kinnos
Stock and Other Ownership Interests - Kinnos
Research Funding - Kinnos
Patents, Royalties, Other Intellectual Property - Kinnos
 
Shilpa Grover
Employment - UpToDate
Honoraria - Novartis (I)
 
Michael Dougan
Consulting or Advisory Role - Genentech; Novartis; Tillotts Pharma
 
Ryan J. Sullivan
Consulting or Advisory Role - ACI Clinical; Array BioPharma; Asana Biosciences; Merck; Novartis; Replimune; Syndax; WorldCare Clinical, LLC
Research Funding - Aeglea Biotherapeutics (Inst); Amgen (Inst); Asana Biosciences (Inst); BioMed Valley Discoveries (Inst); Compugen (Inst); Deciphera (Inst); Lilly (Inst); Merck (Inst); Moderna Therapeutics (Inst); Neon Therapeutics (Inst); Roche/Genentech (Inst); Sanofi (Inst); Viralytics (Inst)
Other Relationship - Boehringer Ingelheim
 
Anita Giobbie-Hurder
No Relationships to Disclose
 
Steven Blum
Stock and Other Ownership Interests - Alimera Sciences; Kronos Bio
Consulting or Advisory Role - Third Rock Ventures; Two River Group
 
Jeffrey Joseph Ishizuka
No Relationships to Disclose
 
Taha Qazi
No Relationships to Disclose
 
Rawad Elias
No Relationships to Disclose
 
Kruti Vora
No Relationships to Disclose
 
Alex Ruan
No Relationships to Disclose
 
William Martin-Doyle
No Relationships to Disclose
 
Lauren Eastman
No Relationships to Disclose
 
Meredith Davis
No Relationships to Disclose
 
Maria Gargano
No Relationships to Disclose
 
Rizwan Haq
Consulting or Advisory Role - Tango Therapeutics
Research Funding - Bristol-Myers Squibb; Novartis
Patents, Royalties, Other Intellectual Property - Patents issued: Mass General Hospital, co-inventor (2014) Patents pending: Dana-Farber Cancer Institute, co-inventor
 
Elizabeth Iannotti Buchbinder
Employment - Alexion Pharmaceuticals (I); Biodesix (I); Sanofi (I)
Consulting or Advisory Role - Array BioPharma; Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb; Checkmate Pharmaceuticals; Lilly; Merck; Novartis
 
Patrick Alexander Ott
Consulting or Advisory Role - Array BioPharma; Bristol-Myers Squibb; Celldex; CytomX Therapeutics; Genentech; Merck; Novartis; Pfizer
Research Funding - ARMO BioSciences (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Celldex (Inst); CytomX Therapeutics (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Merck (Inst); Neon Therapeutics (Inst); Pfizer (Inst)
Expert Testimony - Boehringer Ingelheim
 
F. Stephen Hodi
Employment - Dana-Farber Cancer Institute
Stock and Other Ownership Interests - Apricity Health; Torque
Consulting or Advisory Role - 7 Hills Pharma; Aduro Biotech; Bayer; Bristol-Myers Squibb; Compass Therapeutics; EMD Serono; Genentech/Roche; Merck Sharp & Dohme; Novartis; Partners Therapeutics; Partners Therapeutics; Pfizer; Pionyr; Rheos Medicines; Sanofi; Surface Oncology; Takeda; Torque; Verastem
Research Funding - bristol-myers squibb (Inst); Genentech/Roche (Inst); Merck Sharp & Dohme (Inst); novartis (Inst)
Patents, Royalties, Other Intellectual Property - Angiopoietin-2 Biomarkers Predictive of Anti-immune checkpoint response (Inst); Compositions and Methods for Identification, Assessment, Prevention, and Treatment of Melanoma using PD-L1 Isoforms; Methods of Using Pembrolizumab and Trebananib (Inst); patent pending as per institutional policy; patent pending royalties received on MICA related disorders application to institution per institutional IP policy
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis
Other Relationship - Bristol-Myers Squibb; Genentech/Roche
 
Osama E. Rahma
Employment - Outcomes4me
Leadership - Outcomes4me
Honoraria - Alaunus Global; Clinical Care Options; Leerink; Merck; MI Bioresearch; PRMA Consulting
Consulting or Advisory Role - Alcimed; Celgene; Defined Health; Five Prime Therapeutics; Genentech; Gfk; GlaxoSmithKline; Imvax; Leerink; Leerink; Maverick Therapeutics; Merck; PureTech; Putnam Associates
Research Funding - Amgen (Inst); Merck
Patents, Royalties, Other Intellectual Property - PD-1/PD-L1 (Inst); Pending patent (DFCI 2386.010) (Inst)
Travel, Accommodations, Expenses - Clinical Care Options; Genentech; Merck; PRMA Consulting; PureTech